Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evolocumab use in Greece is associated with early and sustainable reductions in low-density cholesterol (LDL-C) and high persistence to therapy: Results from the Greek cohort analysis of the observational HEYMANS study.
Vlachopoulos C, Massia D, Kochiadakis G, Kolovou G, Patsilinakos S, Bridges I, Sibartie M, Dhalwani NN, Liberopoulos E, Ray KK. Vlachopoulos C, et al. Among authors: dhalwani nn. Hellenic J Cardiol. 2023 Nov-Dec;74:74-76. doi: 10.1016/j.hjc.2023.09.003. Epub 2023 Sep 18. Hellenic J Cardiol. 2023. PMID: 37730147 Free article. No abstract available.
Evolocumab is initiated in Central and Eastern Europe at Much Higher LDL-C Levels than Recommended in Guidelines: Results from the Observational HEYMANS Study.
Blaha V, Margoczy R, Petrov I, Postadzhiyan A, Raslova K, Rosolova H, Bridges I, Dhalwani NN, Zachlederova M, Ray KK. Blaha V, et al. Among authors: dhalwani nn. Eur Cardiol. 2023 Apr 25;18:e36. doi: 10.15420/ecr.2023.18.PO19. eCollection 2023. Eur Cardiol. 2023. PMID: 37405342 Free PMC article. Review. No abstract available.
Evolocumab is Initiated in Central and Eastern Europe at Much Higher LDL-C Levels Than Recommended in Guidelines: Results from the Observational HEYMANS Study.
Blaha V, Margoczy R, Petrov I, Postadzhiyan A, Rašlová K, Rosolová H, Bridges I, Dhalwani NN, Zachlederova M, Ray KK. Blaha V, et al. Among authors: dhalwani nn. J Cardiovasc Pharmacol Ther. 2023 Jan-Dec;28:10742484231172847. doi: 10.1177/10742484231172847. J Cardiovasc Pharmacol Ther. 2023. PMID: 37218974 Free article.
Inflammation and Erythropoiesis-Stimulating Agent Response in Hemodialysis Patients: A Self-matched Longitudinal Study of Anemia Management in the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Karaboyas A, Morgenstern H, Fleischer NL, Vanholder RC, Dhalwani NN, Schaeffner E, Schaubel DE, Akizawa T, James G, Sinsakul MV, Pisoni RL, Robinson BM. Karaboyas A, et al. Among authors: dhalwani nn. Kidney Med. 2020 Mar 26;2(3):286-296. doi: 10.1016/j.xkme.2020.01.007. eCollection 2020 May-Jun. Kidney Med. 2020. PMID: 32734248 Free PMC article.
40 results